Clinical Trial of Aplidin® in Patients With Primary Myelofibrosis
Status:
Completed
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
This is an open-label, Phase II Clinical Trial of Aplidin® (plitidepsin) in Patients with
Primary Myelofibrosis and post polycythemia vera/essential thrombocythemia (Post-PV/ET)
Myelofibrosis.